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Introduction: Self-management has been identified as an important opportunity to improve
health outcomes among cancer survivors. However, few evidence-based interventions are
available to meet this need.
Methods: The effectiveness of an adapted version of the Chronic Disease Self-
Management Program for cancer survivors called Cancer Thriving and Surviving was
evaluated in a randomized trial. Outcomes were assessed at baseline and 6-months
post program via written survey among 244 participants in Colorado. Repeated measures
analysis was used to analyze pre/post program change.
Results: Statistically significant improvement was observed among those in the inter-
vention in the following outcomes: Provider communication (+16.7% change); depres-
sion (−19.1%); energy (+13.8%); sleep (−24.9%) and stress-related problems (−19.2%);
change over time was also observed in the controls for energy, sleep, and stress-related
outcomes though to a lesser degree. Effect sizes of the difference in change over time
observed indicate a net beneficial effect for provider communication (0.23); and decreases
in depression (−0.18); pain (−0.19); problems related to stress (−0.17); and sleep (−0.20).
Conclusion: Study data suggest that the self-management support from adaptation of
the CDSMP can reach and appeal to cancer survivors, improves common concerns in this
population, and can fill an important gap in meeting the ongoing need for management of
post-diagnosis issues in this growing segment of the U.S. population.
Keywords: cancer survivorship, self-management support, patient education, community-based research,
effectiveness trial
INTRODUCTION
The estimated lifetime risk of developing cancer is 45% among
men and 38% among women, with an expected total of 1.6 mil-
lion new cancer cases in 2012 (1). More individuals are living
longer due to improvements in early detection and treatment, and
therefore, the number of cancer survivors in the U.S. has dramat-
ically increased. Current estimates suggest that there are over 13
million survivors alive today in the U.S., with an estimated 18 mil-
lion at the end of the decade; an estimated 65% of all survivors
live 5 years or more. This dramatic increase in the survivor popu-
lation has consequences for both the health of survivors and the
healthcare system. For example, many survivors experience late
and long-term effects from cancer and its treatment. Pain, fatigue,
depression, impaired physical function, and fear of recurrence are
among the most common consequences of cancer as described in
the landmark report by the Institute of Medicine, “From Cancer
Patient to Cancer Survivor: Lost in Transition” (2). This Report
also concluded that the care of cancer survivors is fragmented
and poorly coordinated and that self-management support can
help promote the delivery of quality care and improved health
outcomes in this population. Further, cancer survivors die from
non-cancer causes at a rate higher than the general population (3,
4) likely due to the long-term side effects of cancer and its treat-
ment and risk factors common to both cancer and non-cancer
causes of death.
The Chronic Care Model [CCM; (5)] is a rigorously evaluated
and widely adopted approach to care management for chronic
conditions and features self-management support as one of the
key components for assuring quality healthcare. Self-management
is defined as comprehensive engagement of the patient in prob-
lem solving, decision making, and daily health-related behaviors
in partnership with their healthcare provider and community (6).
A 2007 review by Nolte et al. (7) found many benefits from self-
management programs are also relevant to survivorship such as:
www.frontiersin.org April 2015 | Volume 2 | Article 214 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risendal et al. Self-management program for cancer survivors
improved knowledge, acquisition of skills, symptom management,
and ability to self-monitor health and healthcare needs.
The Chronic Disease Self-Management Program (CDSMP)
is one of the few evidence-based interventions available across
a variety of health-related conditions for comprehensive self-
management support (8). While there are now specialized ver-
sions for some chronic conditions such as diabetes, chronic pain,
HIV/AIDS, and arthritis1, an adapted version for cancer survivors
has only recently been developed for use and testing in the U.S. The
purpose of the current paper is to describe the findings from the 6-
month outcome evaluation of cancer thriving and surviving (CTS)
among over 200 cancer survivors in the post-treatment phase who
participated in a randomized trial in Colorado between 2011 and
2013. In this paper, we report the effectiveness of the evidence-
based CDSMP translated to cancer survivors by comparing the
magnitude of the effect observed in the intervention vs. control
group over time.
MATERIALS AND METHODS
INTERVENTION
Developed by researchers from the Stanford Patient Education
Research Center at Stanford University, the model for the CDSMP
program entails a series of six weekly small-group sessions led by
trained facilitators. The model is based on social cognitive theory
(9) to focus on building skills, sharing experiences, and support
among the participants to maximize engagement. Sessions follow
a standardized curriculum detailed in a program manual to pro-
mote fidelity to the following program elements: brainstorming,
action plan formulation, action plan feedback, problem solving,
and decision making (10).
In brief, adaptations to the CDSMP for cancer survivors were
guided by the research of Foster et al. (11) and the subsequent
conceptual model (12) to include restoration of self-confidence,
adjustment to changed self, and confidence to self-manage cancer-
related problems. The resultant CTS curriculum was initially
developed by Macmillan Cancer support in the U.K and subse-
quently modified by the Stanford Patient Education Center to
incorporate language more common to the U.S.
Researchers at the Colorado School of Public Health (CSPH)
partnered with the Consortium for Older Adult Wellness (COAW)
to deliver the program. COAW is a community-based agency with
state-wide license to deliver the evidence-based CDSMP. Individ-
uals who were already trained and licensed to provide the CDSMP
workshops and who were also cancer survivors completed a 2-
day cross-training program led by the Stanford Patient Education
Center to ensure fidelity to the model.
RECRUITMENT
Cancer survivors throughout the “Front Range” of Colorado,
where roughly two-thirds of state’s population resides, were
approached in a variety of outreach methods including: inter-
actions with cancer center staff and brochures left at medical
offices, mailed to homes using mailing lists from local cancer sur-
vivor programs, distributed at cancer survivor local events, and
media. Potential respondents identified from these routes were
1http://patienteducation.stanford.edu/programs/cdsmp.html
contacted by COAW personnel (located in Denver, also within
the Front Range) to assess interest and eligibility for participation
in the program. Participants were allocated to the intervention
or control groups for the analytic evaluation. Inclusion in the
program required participants to be over the age of 21 years and
diagnosed with cancer that required radiation, surgical, or adju-
vant chemotherapy treatment, but not to be in active treatment at
the time of enrollment. Persons currently receiving maintenance
therapies for cancer delivered after completion of primary treat-
ment (such as anti-hormonal treatments) were eligible. Support
persons/caregivers of the above were also allowed to attend. All
persons had to speak and read/write in English, and also agree
to attend in-person classes and arrange transportation to attend
classes. Persons in end-of-life care or currently undergoing active
treatment for cancer were excluded, as were individuals over the
age of 79 years. Approval to conduct the research was obtained
by the Colorado Multiple Institutional Review Board; participants
provided signed informed consent. No incentives were offered to
potential participants.
INTERVENTION DELIVERY
Twenty-seven workshops were delivered in Colorado between
August 2011 and January 2013. Each workshop consisted of six
2.5 h sessions led by two facilitators as described above. Facilitators
were periodically observed by Master Trainers and provided
written feedback to monitor fidelity and quality assurance.
DATA COLLECTION
Written self-administered surveys were collected from participants
at baseline and for final follow-up measure (6 months after pro-
gram completion). Instruments were from the Stanford CDSMP
Evaluation2 and have been widely used in many health and aging
studies (13, 14) and are viewed as pragmatic measures (15).
Participants were asked at baseline to self-report demographic
characteristics (age, gender, marital status, race/ethnicity) as well
as cancer-related history (caregiver, time since diagnosis, type of
cancer, co-morbid conditions).
STUDY DESIGN
This study deployed a randomized controlled trial design, where
participants were randomized in a 2:1 ratio following consent to
the intervention vs. control group. Since the purpose of this study
was to evaluate effectiveness rather than efficacy, we intention-
ally sought to maximize the number of participants receiving the
intervention so that we could gain more experience to inform
implementation and also to improve the generalizability of the
results by broadening the characteristics and delivery while still
utilizing a valid comparison group. Participants were random-
ized to group assignment using a random number generator by
the research coordinator who was separate from the intervention
delivery. Caregivers/support persons were randomized as a pair
with their survivor so they could attend sessions together, and
therefore, not counted toward the 2:1 ratio. Persons who consented
and were randomly assigned to the control group were offered to
attend the CTS workshops after the final evaluation assessment was
2http://patienteducation.stanford.edu/research
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collected at 6-months following consent; thus their data served as
the control for those randomized to the intervention group. This
design was chosen to facilitate retention of controls over the 6-
month time period between consent and assessment of the main
outcome measures at 6 months post-program (in order to mirror
the CDSMP evaluation plan), and to gain more experience with
intervention delivery.
OUTCOMES
Our hypothesis was that the intervention would produce improve-
ment in outcomes directly related to health beliefs and behav-
iors related to physical activity (days active/minutes active), self-
efficacy, and communication with providers. Secondary outcomes
of interest included self-reported health and symptoms (health
status, depression, energy, pain, sleep, and stress).
The following describes measures employed in this study:
• Days active, minutes active: days active, minutes active: respon-
dents were asked how many days in the past week they were
physically active or exercising for at least 30 min and how many
total minutes in the past week they were physically active or
exercising, including brisk walking, running, dancing, bicy-
cling, water exercise, etc., that may cause faster breathing or
heartbeat, or feeling warmer. For the current analyses, we are
using continuous count data for number of minutes exercised
and number of days exercised. Respondents were asked how
many days in past week they were physically active or exer-
cising for at least 30 min and how many total minutes in the
past week they were physically active or exercising (includ-
ing brisk walking, running, dancing, bicycling, water exercise,
etc.) that may cause faster breathing or heartbeat, or feeling
warmer. For the current analyses, we are using continuous count
data for number of minutes exercised and number of days
exercised.
• Participant care seeking behaviors (communication with physi-
cians): communication with a physician was measured using a
three-item scale, which asked participants if they did the follow-
ing things when visiting a physician: prepare a list of questions,
ask questions about things they want to know or do not under-
stand, and discuss personal problems. Scores for these items
ranged from never (0) to always (5). If respondents answered
at least two of these items, the scale was calculated as the mean
of the non-missing items. Higher scores represent better com-
munication with a physician. An increase or positive change is
desirable.
• Self-efficacy: this was measured using a six-item scale, which
asked participants how confident they were keeping fatigue,
physical discomfort, pain, emotional distress, and other symp-
toms and health problems caused by cancer diagnosis and
treatment from interfering with the things they want to do; they
were also asked about their confidence doing different tasks and
activities needed to manage their cancer diagnosis and treat-
ment to reduce their need to see a doctor. Responses to these
items ranged from Not at all confident to (1) to Totally confi-
dent (10). If respondents answered at least four of these items,
the scale was calculated as the mean of the non-missing items.
Higher scores represented greater confidence. An increase or
positive change was desired.
• Health status: we asked respondents to rate their health on a
scale of excellent (1) to poor (5). A low value on this scale
indicates better health; a decrease or negative change from the
base-line period to the final period for this variable.
• Health symptomatology:
o Energy: we asked patients five questions about their level of
energy: (1) Do you feel worn out?, (2) Did you have a lot
of energy?, (3) Did you feel tired?, (4) Do you have enough
energy to do the things you wanted to do?, and (5) Did you
feel full of pep?. Responses to these items range from none of
the time (0) to all of the time (5). If the respondent replied
to at least three of these five items, the scale was calculated as
the mean of the non-missing items with the two negatively
worded items (1 and 3) reversed coded. A high score on this
scale represents more energy. An increase or positive change
for scale is desirable.
o Pain, stress, and sleep problems: these three visual scales
ranged from no problem (0) to very big problem (10). A high
score on these scales represents more problems. A decrease
or negative change on this scale was desired.
• Depression: participants completed the eight-item Personal
Health Questionnaire Depression Scale (16). The items’
responses ranged from Not at all (0) to Nearly Everyday (3).
Sum scores ranged from 0 to 24. Higher scores indicate more
severe depression. A decrease or negative change in these items
was desired.
STATISTICAL ANALYSIS
Pearson Chi Square and Fisher exact tests were used in Table 1 to
compare the demographic characteristics of the intervention and
control groups.
In order to determine if the outcome variables showed the
change in the desired direction over time, we used repeated mea-
sures analysis with an unstructured variance covariance matrix.
This method models the correlations between repeated observa-
tions from the same individual. It also utilizes available data for all
participants, regardless of final measure completion allowing for a
form of intent to treat analysis, which reduces potential drop-out
bias. A case is only excluded if they did not answer a sufficient
number of items on both the pre- and the post-test. If they have
enough data for either time period, they were included in the sam-
ple. Data from participants were only excluded if they did not
supply an adequate number of responses required for each instru-
ment; if they had enough responses for either time point the data
were included in the analysis. Each of the 10 outcomes described
above served as dependent variables in models with no intercepts
and a time period (baseline, final) by group assignment interaction
as the independent variable. Parameters resulting from this model
include an estimated mean for each group at each time period
(17). Contrasts were estimated to determine change from baseline
to final and differences between groups.
We conducted additional analyses to determine if the effect of
the intervention was moderated by age. These models were similar
to the models described above except a three-way interaction of
age group (<65, 65+), treatment group (intervention vs. control),
and time period since diagnosis replaced the two-way interaction.
No interaction effect was observed, so the original analyses are
presented.
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Table 1 | Characteristics at baseline among study participants*, by
treatment group (n, %).
Characteristic Intervention
(n = 169*)
Control
(n = 89*)
p-Value
Age (years)
<50 33 (19.5) 19 (21.4) 0.93
50–64 81 (47.9) 41 (46.1)
65+ 55 (32.5) 29 (32.6)
Sex
Male 38 (22.5) 9 (10.1) 0.01
Female 131 (77.5) 80 (89.9)
Marital status
Married/partner 106 (62.7) 47 (52.8) 0.19
Single 62 (36.7) 42 (47.2)
1 (0.6)
Hispanic ethnicity 13 (7.7) 6 (6.7) 0.78
Race
White 145 (85.8) 74 (83.2) 0.57
Black 14 (8.3) 5 (5.6) 0.43
Other** 11 (6.5) 11 (12.4) 0.11
Insurance
Medicaid 10 (5.9) 3 (3.4) 0.55
Medicare 83 (49.1) 31 (34.8) 0.03
HMO (Kaiser) 28 (16.6) 8 (9.0) 0.09
Private 63 (37.3) 34 (38.2) 0.88
VA/Other 4 (2.4) 2 (2.3) 1
None 6 (3.6) 3 (3.4) 1
Employment
Working 47 (27.8) 38 (42.7) 0.04
Not working 49 (29.0) 15 (16.9)
Retired 49 (29.0) 25 (28.1)
Other 11 (6.5) 2 (2.3)
Missing 13 (7.7) 9 (10.1)
Self-rated health
Excellent 13 (7.7) 8 (9.0) 0.76
Very good 52 (30.8) 29 (32.6)
Good 77 (45.6) 35 (39.3)
Fair 25 (14.8) 15 (16.9)
Poor 2 (1.2) 1 (1.1)
Missing 0 (0.0) 1 (1.1)
Years since diagnosis 18 (10.7)
<1 73 (43.2) 7 (7.9) 0.87
1–3 44 (26.0) 41 (46.1)
4–9 29 (17.2) 24 (27.0)
10+ 5 (3.0) 13 (14.6)
Missing 4 (4.5)
Cancer type
Breast 66 (39.1) 66 (74.2) <0.0001
Lymph./Hodgkins 27 (16.0) 4 (4.5) 0.01
Prostate 12 (7.1) 4 (4.5) 0.41
Colorectal 11 (6.5) 2 (2.3) 0.23
Endometrial/uterine 7 (4.1) 1 (1.1) 0.27
Ovary 9 (5.3) 0 (0.0) 0.03
Multiple myeloma 6 (3.6) 2 (2.3) 0.72
(Continued)
Characteristic Intervention
(n = 169*)
Control
(n = 89*)
p-Value
Lung 9 (5.3) 1 (1.1) 0.17
Leukemia 6 (3.6) 4 (4.5) 0.74
Melanoma 4 (2.4) 1 (1.1) 0.66
***Other 43 (25.4) 6 (6.7) 0.0003
*Includes persons diagnosed with cancer (excludes participating caregivers).
**Anyone who did check black or white including those who checked Asian,
Native American, or other.
***Including cancer of the cervix, bladder, bone, brain, esophagus, kidney, liver,
pancreas, thyroid, or other.
Effect sizes were calculated using Cohen’s d (18), which is
defined as the difference between two means divided by the pooled
SD of the groups. Analysis was conducted using the Mixed Pro-
cedure of SAS 9.4. Unlike statistical significance, effect size is not
dependent on sample size for interpretation. Effect size is a quanti-
tative measure of the relative strength of the intervention whereby
a larger absolute effect size value always indicates a stronger effect.
RESULTS
RECRUITMENT AND RANDOMIZATION
The activities described above resulted in 493 referrals (see Con-
sort Diagram, Figure 1). Since this was an effectiveness study, the
eligibility criteria were quite broad and only 12 of these individ-
uals were ineligible (reasons included: did not receive treatment
for cancer, over age 79, and still in treatment). A total of 158
subjects ultimately did not enroll as follows: did not show for
first session to sign consent form (n= 37); not interested after
learning more (n= 31); unreachable/voicemail left (n= 38); bad
timing/inconvenient time/location (n= 34); in cancer treatment
because cancer returned following initial outreach (n= 18). This
resulted in a total of 323 eligible subjects enrolled, including 267
persons diagnosed with cancer and 56 caregivers/supporters. Ran-
domization resulted in 169 survivors (and 29 of their caregivers)
assigned to the intervention and 89 survivors (and 15 of their care-
givers) assigned to the control. Only the survivors (not caregivers)
in each group were utilized for the comparisons described in this
paper (see below).
PARTICIPATION/COMPLETION
The average number of participants in each workshop was
8.2± 2.7; half the sessions had 7–9 participants (48.2%) with
the remainder of workshops approximately evenly split between
5and 6 (29.6%) or 10 or greater participants (22.2%). The major-
ity of participants (84%) completed four or more of the six
sessions in each workshop (data not shown). Of the 169 per-
sons diagnosed with cancer who were assigned to the inter-
vention, 117 completed the final program measure (69.2%). A
similarly high percentage of persons diagnosed with cancer and
assigned to the control group (n= 89) completed the final measure
(n= 72; 81.0%). Baseline characteristics of completers and non-
completers were compared (data not shown) with only one factor
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(gender) significantly different between groups (more women
in the intervention group); differences by intervention vs. con-
trol group in regard to completion were not observed. Base-
line characteristics by group assignment are shown in Table 1;
the groups were quite similar in accordance with major char-
acteristics with the exception of gender and cancer type. Dif-
ferences in insurance type and employment status were also
present.
MISSING DATA/DATA ENTRY ERRORS
Five percent of surveys entered were checked at random for data
entry errors; these checks were performed by study personnel
|
|
| |
| |
* Subjects included in repeated measures outcome analysis
Baseline 
Survivors Caregivers
169* (97.7%) 29 (80.5%)
Baseline
Survivors Caregivers
89* (94.7%) 15 (75.0%)
Final (6 month measure)
Survivors Caregivers
117* (69.2%) 20 (69.0%)
Final (6 month measure
Survivors Caregivers
72* (81.0%) 7 (46.7%)
Consented
323
Eligible
481
Program Referrals/Contacts
493
Randomized to Intervention 
Survivors Caregivers
173 36
Randomized to Lagged Control 
Survivors Caregivers
94 20
Decided not to join
158
Ineligible
12
FIGURE 1 | Study participation.
who did not perform the initial data entry and demonstrated a
detected error rate of <1%. A total of 448 surveys (258 base-
line, 190 post-program) were collected. The number of surveys
with complete data for specific outcomes ranged from 427 to
448, indicating that missing data within available surveys was
minimal.
OUTCOME MEASURES
Baseline, final values measured at 6-month post-program, and
change (%) values over time observed among participants in
the intervention as compared to the control group are shown in
Table 2. Statistically significant change over time among partici-
pants in the intervention was observed in the following outcomes:
provider communication, depression, energy, sleep, and stress.
Where change was observed in the controls, they were smaller
among most outcomes.
EFFECT SIZES
Effect sizes calculated by Cohen’s d are shown in Table 3 for
the intervention, control, and the difference in degree of change
between the two groups. A beneficial effect was observed over time
among participants in the intervention for many outcomes, con-
sistent with the results in Table 2. For example, medium effect sizes
(0.5–0.75) were shown for provider communication, depression,
energy, sleep, and stress. In contrast, small effect sizes (0.16–
0.35) or no effects were observed in the control for these same
outcomes.
When the effect size for the difference in change in the inter-
vention group relative to the change in the control was evaluated,
a small effect was observed in regard to provider communica-
tion (0.23), sleep (−0.20), and very small effect for stress-related
problems (−0.17).
In addition to the results shown in Tables 2 and 3, we also
examined the role of interaction between age, time since diagno-
sis, and outcomes of interest and did not detect possible effect
modification (data not shown).
Table 2 | Baseline, final, change, and % change between 6-month outcome measures, by intervention vs. control.
Intervention (n = 169) Lagged control (n = 89)
6-month outcome Baseline value
mean (SE)
Final value
mean (SE)
Change
mean (SE)
Change (%) Base-line value
mean (SE)
Final value
mean (SE)
Change
mean (SE)
Change (%)
Days active 3.0 (0.2) 3.0 (0.2) 0.1 (0.2) 1.7 2.9 (0.2) 2.8 (0.3) −0.1 (0.3) −4.3
Minutes active 143.4 (12.3) 192 (27.3) 48.7 (28.2) 34.0 124.4 (17.0) 155.1 (35.0) 30.6 (36.5) 24.6
Self-efficacy 70.2 (1.7) 72.4 (2.0) 2.3 (1.9) 3.2 73.6 (2.3) 77.7 (2.6) 4.0 (2.5) 5.5
Provider communication 3.1 (0.1) 3.7 (0.1) 0.5** (0.1) 16.7 3.5 (0.1) 3.8 (0.1) 0.3 (0.1)* 7.4
Depression 8.5 (0.4) 6.9 (0.5) 1.62** (0.5) −19.1 7.8 (0.6) 7.2 (0.6) −0.7 (0.6) −8.5
Health status 2.7 (0.1) 2.7 (0.1) 0.0 (0.1) 0.4 2.7 (0.1) 2.6 (0.1) −0.1 (0.1) −2.2
Energy 2.2 (0.1) 2.5 (0.1) 0.3** (0.1) 13.8 2.1 (0.1) 2.4 (0.1) 0.3 (0.1)* 12.9
Pain 3.2 (0.2) 3.0 (0.2) −0.3 (0.2) −8.0 3.5 (0.3) 3.7 (0.3) 0.2 (0.3) 5.9
Sleep problems 5.3 (0.2) 4.0 (0.3) −1.3** (0.2) −24.9 5.6 (0.3) 4.9 (0.3) −0.7 (0.3)* −12.7
Stress problems 5.1 (0.2) 4.1 (0.2) −1.0** (0.22) −19.1 5.4 (0.3) 4.8 (0.3) −0.6 (0.3)* −10.3
*Statistically significant change between baseline and final measures; p<0.05.
**Statistically significant change between baseline and final measures; p<0.001; repeated measures analysis.
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Table 3 | Effect sizes (Cohen’s d ) in 6-month outcomes, by intervention
vs. control and change between groups.
Outcome Effect size in
intervention
group
(n = 169)
Effect size
observed
in control
group
(n = 89)
Effect size
of difference in
change between
intervention
and control
Days active 0.03 −0.05 0.06
Minutes active *0.25 0.12 0.06
Self-efficacy 0.17 *0.23 0.08
Health status 0.02 −0.08 0.08
Provider communication **0.75 *0.29 *0.23
Depression **−0.50 *−0.16 *−0.18
Energy **0.51 *0.35 0.03
Pain −0.17 0.11 *−0.19
Sleep problems **−0.72 *−0.31 *−0.20
Stress problems **0.63 *−0.28 *−0.17
*Borderline/small effect (0.2).
**Medium effect (0.5).
DISCUSSION
These outcome analyses of the adapted version of the Stanford
CDSMP for cancer survivors indicate demonstrable beneficial
effects in many outcomes (Tables 2 and 3); further, no out-
comes worsened following participation in the intervention when
we evaluated the group-level comparisons. The outcomes that
improved with the CTS program (e.g., provider communica-
tion, depression, sleep problems, and stress-related problems; see
Table 3) are particularly salient to the challenges faced by cancer
survivors. For example, fragmented and poorly coordinated sys-
tems of care make provider communication an important skill for
the cancer survivor. Sleep, depression, and pain are commonly
reported symptoms as described in the previously cited IOM
report, and it is notable that a non-medical, relatively inexpensive
and brief educational intervention delivered in the community set-
ting had positive impact on these common yet potentially serious
issues.
Improvement over time between the baseline and 6-month
measure was also observed in three domains among the controls,
although generally to a lesser degree than those in the intervention
(see Table 2). For example, we observed a 19.1% mean difference
depression scores measured by the PHQ-8 over time in the inter-
vention group in contrast to only 8.5% decline in the controls over
time. Further, the difference over time was statistically significant
in the intervention but not in the control group. This difference
in the magnitude of effect over time observed in the intervention
vs. control groups is illustrated by comparing effect size. Effect
sizes take into account the size of measurement error in the data
but do not rely on sample size or statistical significance for their
interpretation; therefore, they are meaningful when evaluating the
relative impact of an intervention. In the case of depression, for
example, the effect size in the intervention group over time was a
medium/large effect (−0.50) vs. a small effect (−0.16) in controls
(Table 3). Similarly, striking differences in effect size among the
intervention vs. control groups were observed for pain (−0.17 vs.
0.11), suggesting a net small/medium benefit since the trend in the
controls was to worsen over time. Although sample size does not
directly impact the calculation of effect size, the finding of effect
size differences is considered meaningful when observed in larger,
well-designed studies such as reported here.
The heterogeneous nature of our study population in this
intentionally pragmatic design allows us to estimate the benefits
of the program in the real world by examining effect sizes
(i.e., effectiveness). However, it also dampens the ability to detect
statistically significant differences because by design, it does not
use carefully constructed homogeneous study populations to min-
imize variation as in efficacy trials. The ability to demonstrate
statistical significance in an effectiveness evaluation is strongly
influenced by the number of persons in relevant subgroups where
the intervention may be more or less efficacious; however, these
subgroups are not necessarily known to the researchers or able to
be detected in the real-world setting of the evaluation. The fact that
we that we did not see statistically significant difference between
the change over time in the intervention vs. control is likely a
consequence of the heterogeneous nature of our real-world study
population; but the difference in effect sizes represents the impact
of the intervention by measuring the magnitude of this difference
observed over time in the two groups and highlights the external
validity of our findings.
Other studies of the CDSMP have similarly evaluated effect
size to evaluate the impact of the program. A 2008 Cochrane
Collaboration review (11) of self-management education inter-
ventions demonstrated effect sizes observed in multiple reports
of other populations similar to or smaller than those observed in
the current study. For example, of the 17 randomized trials of lay-
led self-management programs in this review demonstrated effect
sizes for pain of 0.10 (current study 0.11) and depression of 0.16
(current study 0.18).
Although we did not observe an effect with self-efficacy as
observed in other trials (ranging from 0.30 to 0.40), we did observe
an improvement in provider communication (0.23). Cancer sur-
vivors in the post-treatment period neither have the frequency nor
regularity of health system interaction as with other chronic con-
ditions such as asthma and diabetes and therefore may not have
had ample opportunity to use their self-management skills, which
could be the cause of the neutral scores on this domain. However,
the improvement observed in provider communication is a related
and similarly important skill for this population. Provider com-
munication is a necessary component of the Chronic Care Model,
which promotes collaboration between patients and providers in
partnership to achieve improved outcomes (5). This is especially
important in survivors who may experience both late and long-
term side effects from treatment that can change over time, and
may require ongoing vigilance and care.
Another observation from our study could be explored in future
research is our observation of improvement over time in the
control group, which although was to a lesser degree, was sta-
tistically significant in three constructs (energy, sleep, and stress).
Other researchers have suggested that positive adjustment or post-
traumatic growth over time following a stressful event such as
cancer can occur (19–21). Thus, one possible explanation for
this finding is that survivors have accepted a “new normal” and
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therefore the increase over a time is a reflection of this perception.
Additionally, there may be some endogenous aspects to a survivor’s
improvement that could be capitalized upon in future iterations
of the program.
Limitations of this study are that we may not have quantita-
tively measured all the outcomes of relevance in this population.
For example, we did not directly measure social support or the
unique benefits among caregivers such as family communication.
Additionally,while the majority of respondents completed the final
measure, we were unable to measure final outcomes in all respon-
dents. However, we utilized repeated measures analysis to utilize
data from all respondents regardless of completion to minimize
this potential source of bias. Additionally, we chose to include sur-
vivors in the post-treatment stage only to support the unmet need
for transition support. Although it is reasonable to expect that
similar benefits would be observed in survivors at other points
in the continuum, additional evaluations with survivors at other
time points should be conducted.
A recent review of 16 self-management programs that have been
utilized with a variety of cancer survivor populations promotes
the use of the Chronic Care Model and particularly support for
self-management in addressing needs across the continuum from
diagnosis to survivorship (22). Aspects of self-management high-
lighted in this review as beneficial for survivors are also highly vis-
ible “active ingredients” in the CTS program and include: goal set-
ting, realistic action plans, partnering with providers, and identify-
ing aspects of health and healthcare that patients can self-manage
with confidence. Although the attention to self-management inter-
ventions in this population is increasing, this review concludes
that there is an urgent need for the translation of these inter-
ventions into practice, particularly in the post-treatment period.
The authors suggest that interventions at this point in time can
be especially helpful in easing transition to less regular contact
with oncologists and dealing with the psychosocial and functional
challenges into survivorship.
Contemporary views of effectiveness have evolved to suggest
that it is influenced not only by efficacy, but reach of the program
as well as implementation with fidelity (23). Our enrollment of
over 300 cancer survivors and caregivers to this effectiveness study
and the diversity of the study population according to cancer type,
time since diagnosis, age, and other characteristics as shown in
Table 1 suggests that this program can reach and appeal to the gen-
eral cancer population. By partnering with a community agency
with state-wide reach for delivery of the original CDSMP Program
with certified facilitators and extensive experience in delivering
the program, we were further able to deliver the new adapted ver-
sion in keeping with the principles of original program method.
When taken in sum, these outcome and implementation data
demonstrate that survivors who participate in the CTS program
experience a small but measurable net gain over time in impor-
tant survivorship domains in comparison to those who receive
no intervention, and that the program can fill an important gap
in meeting the ongoing need for management of post-diagnosis
issues in this growing segment of the U.S. population.
The implementation of self-management support is partic-
ularly challenging in the cancer environment for a number of
reasons including the use of multiple specialty care providers
from diagnoses through to treatment and survivorship, lack
of an evidence base to guide follow-up surveillance and deci-
sion making, complex late and long-term side effects requir-
ing detailed patient history and records, and limited oncol-
ogy system capacity. While the delivery of self-management
programs to date has been driven by innovations in primary
care, a recent emerging trend in support of needed system
and policy change for cancer survivors is the establishment of
patient-centered medical homes (PCMH) in the oncology set-
ting (24). Future research is needed to support policy change
to ensure that patients receive self-management support that
is tailored to their cancer needs across oncology and a vari-
ety of other settings, driven by patient needs and preferences.
Additional research is also needed to understand which out-
comes are most relevant in this population toward demonstrat-
ing cost-effectiveness that can inform needed system and policy
change.
Decreased emergency room visits and hospitalizations are of
relevance to cost in other chronic illness populations (14), but
outcomes such as overuse of care/screening may be even more
important for cancer survivors. Patterns of care outcomes are dif-
ficult to track in with multiple payor systems, but policy changes
to support the collection and analysis where possible in Medic-
aid/Medicare or other single-payor systems should be pursued
to further evaluate outcomes from self-management support for
cancer survivors. The CTS has enormous potential to be widely
disseminated by tapping into existing channels in the community
and among providers that have already been established with the
CDSMP Program; however, the successful implementation of self-
management interventions such as the CTS is reliant upon buy-in
by oncology providers, survivors, and the healthcare system to
recognize benefits such as those observed in the current report. As
evidence continues to mount on the effectiveness of the CDSMP
in other chronic disease populations (25, 26), and models of sur-
vivorship care continue to develop, policy and system support for
self-management as a vital and viable component in successful
transition to survivorship is needed.
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